Home

Glaxosmithkline Pharmaceuticals Ltd EPS

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

EPS

₹ 56.27

Last updated on: Dec 26, 2025

Key Highlights

  • The Earning per Share of Glaxosmithkline Pharmaceuticals Ltd is ₹ 56.27 as of 26 Dec 25 .
  • The earning per share of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 7.04 to ₹ 15.07 over 10 quarters. This represents a CAGR of 35.59% .

Historical Earning per Share of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Market Cap

41,756 Cr

EPS

56.3

P/E Ratio (TTM)

43.8

P/B Ratio (TTM)

24.5

Day’s High

2508.85

Day’s Low

2460.0

DTE

0.0

ROE

55.9

52 Week High

3515.95

52 Week Low

1924.3

ROCE

74.6

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20252464.9
24 Dec 20252484.7
23 Dec 20252498.35
22 Dec 20252523.3
19 Dec 20252534.6
18 Dec 20252552.35
17 Dec 20252581.7
16 Dec 20252588.4
15 Dec 20252575.05
12 Dec 20252598

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

41,757

Asset Value

Value addition

16.0 X

2,460

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Glaxosmithkline Pharmaceuticals Ltd41756
Sun Pharmaceutical Industries Ltd412494
Divis Laboratories Ltd170514
Torrent Pharmaceuticals Ltd129044
Cipla Ltd121574
Dr Reddys Laboratories Ltd105919

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to conduct board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M

Read more

19 Apr 25

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

FAQs for EPS of Glaxosmithkline Pharmaceuticals Ltd

What is the EPS of Glaxosmithkline Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Glaxosmithkline Pharmaceuticals Ltd is 56.27. An EPS is the amount of net income attributed to each share of a common stock.

How is Glaxosmithkline Pharmaceuticals Ltd EPS calculated?

The EPS of Glaxosmithkline Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glaxosmithkline Pharmaceuticals Ltd report its EPS?

Glaxosmithkline Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glaxosmithkline Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Glaxosmithkline Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glaxosmithkline Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Glaxosmithkline Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions